Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.3928.99-10.0912.99274.74

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -5.39 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99
Mar2021274.74

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹138.5 Cr -0.6% 7.2% -10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,938.0 Cr -0.6% -3.7% 7.3% Stock Analytics
DIVIS LABORATORIES ₹179,361.0 Cr 2.8% 0.7% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,385.0 Cr 2.4% 2.1% 40.8% Stock Analytics
CIPLA ₹111,220.0 Cr 0.1% 2.2% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,899.0 Cr 0.5% -1.9% 2.2% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-0.6%

7.2%

-10.9%

SENSEX

-1%

-5%

-9.2%


You may also like the below Video Courses